CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Other Accounts Payable
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Other Accounts Payable of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2014-03-20
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable for the quarter ending 2013-12-31 was -$20.55K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable for the quarter ending 2013-09-30 was $29.56K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable for the quarter ending 2013-06-30 was $2.70K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable for the quarter ending 2013-03-31 was -$11.71K, a 121.56% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable for fiscal 2012 was $744.00, a 94.42% decline from fiscal 2011.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable for fiscal 2011 was $13.33K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable for fiscal 2010 was -$30.18K.
| Period end | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 9 month | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|---|---|
| 2013-12-31 | -$20.55K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $9.02K derived: sum of 2 quarters · filed 2014-03-20 | $11.71K derived: sum of 3 quarters · filed 2014-03-20 | $0.00 10-K · filed 2014-03-20 |
| 2013-09-30 | $29.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $32.26K derived: sum of 2 quarters · filed 2013-11-14 | $20.55K 10-Q · filed 2013-11-14 | -$8.91K derived: sum of 4 quarters · filed 2014-03-20 |
| 2013-06-30 | $2.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$9.02K 10-Q · filed 2013-08-14 | -$38.48K derived: sum of 3 quarters · filed 2014-03-20 | -$54.83K derived: sum of 4 quarters · filed 2014-03-20 |
| 2013-03-31 | -$11.71K 10-Q · filed 2013-05-14 | -$41.17K derived: sum of 2 quarters · filed 2014-03-20 | -$57.52K derived: sum of 3 quarters · filed 2014-03-20 | -$65.31K derived: sum of 4 quarters · filed 2014-03-20 |
| 2012-12-31 | -$29.46K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$45.81K derived: sum of 2 quarters · filed 2014-03-20 | -$53.59K derived: sum of 3 quarters · filed 2014-03-20 | $744.00 10-K · filed 2014-03-20 |
| 2012-09-30 | -$16.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$24.13K derived: sum of 2 quarters · filed 2013-11-14 | $30.20K 10-Q · filed 2013-11-14 | -$1.63K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | -$7.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $46.55K 10-Q · filed 2013-08-14 | $14.72K derived: sum of 3 quarters · filed 2013-08-14 | $68.83K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $54.34K 10-Q · filed 2013-05-14 | $22.50K derived: sum of 2 quarters · filed 2013-05-14 | $76.61K derived: sum of 3 quarters · filed 2013-05-14 | $22.73K derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | -$31.84K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $22.27K derived: sum of 2 quarters · filed 2013-03-14 | -$31.61K derived: sum of 3 quarters · filed 2013-03-14 | $13.33K 10-K · filed 2013-03-14 |
| 2011-09-30 | $54.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $230.00 derived: sum of 2 quarters · filed 2012-11-14 | $45.16K 10-Q · filed 2012-11-14 | -$993.00 derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | -$53.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$8.95K 10-Q · filed 2012-08-14 | -$55.10K derived: sum of 3 quarters · filed 2012-08-14 | -$40.14K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $44.93K 10-Q · filed 2012-05-14 | -$1.22K derived: sum of 2 quarters · filed 2012-05-14 | $13.73K derived: sum of 3 quarters · filed 2012-05-14 | |
| 2010-12-31 | -$46.16K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | -$31.20K derived: sum of 2 quarters · filed 2012-03-14 | -$30.18K 10-K · filed 2012-03-14 | |
| 2010-09-30 | $14.96K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $15.97K 10-Q/A · filed 2012-03-06 | ||
| 2010-06-30 | $1.01K 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |